Getty Realty Corp. secured a $200 million senior unsecured term loan to repay its revolving credit facility, including funding part of its recent Refuel transaction. The loan matures in 2028 with options for extensions and carries an effective interest rate of 5.03%. Amendments to the credit agreement also reduced borrowing costs and improved borrowing terms based on the company's credit rating. This move enhances Getty's financial flexibility and reflects confidence in its portfolio and credit profile.
Getty Realty Corp.'s new $200 million unsecured term loan is notable context for readers. For those following the Real Estate sector, 47 US stocks were priced on Pluang as of Oct 20, 2026 02:11 WIB. Of these, only 3 rose while 44 fell, including NLY at USD 17.80 with a -2.36% change and a typical hold time of 92 days, and CCI at USD 80.50 with a -2.14% change and 100% sell order activity.
Dorchester Minerals, L.P. has agreed to acquire mineral and royalty interests covering about 4,300 net royalty acres in three counties within North Dakota's Williston Basin. The deal involves a non-taxable contribution and exchange agreement with an ...
The Hershey Trust Company sold 1,512 common shares under a trading plan but kept voting control through Class B shares. Hershey will report Q3 earnings on October 29, with investors focused on how price increases affected Halloween-season demand. Q2 ...
W. R. Berkley reported mixed Q3 2026 results with earnings per share of $1.17 beating estimates, but revenue fell short at $3.74 billion versus $3.82 billion expected. The company saw premium growth with gross premiums up 3% and net premiums up 1%, s...
GE Aerospace is set to report its Q3 earnings with analysts forecasting a 21.7% rise in earnings per share to $2.02 and nearly 12% revenue growth to about $12.7 billion. Despite consistently beating estimates, the stock has fallen after past reports ...
Silence Therapeutics' stock surged 125.6% to $19.58 following Merck KGaA's agreement to acquire the RNA-interference drug developer for about $1.3 billion in equity value. Merck will pay $20 per share, a 130% premium over the recent closing price. Ot...
